Akero Therapeutics, created in 2017 (United States), belongs to our Top Web Popularity Biotechnology, from 308 sister brands and 1736 competing brands. The Akero Therapeutics brand is owned by NOVO-NORDISK A/S, a company listed in Francfort. The sector of Akero Therapeutics is Biotechnology.
Share price and profitability of the share NOVO-NORDISK A/S (Akero Therapeutics)
Overview of NOVO-NORDISK A/S's share performance with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
